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Infection with Mycobacterium tuberculosis is one of the leading causes of death worldwide. Recognition of M.
tuberculosis by pattern recognition receptors is crucial for activation of both innate and adaptive immune responses. In
the present study, we demonstrate that nucleotide-binding oligomerization domain 2 (NOD2) and Toll-like receptors
(TLRs) are two nonredundant recognition mechanisms of M. tuberculosis. CHO cell lines transfected with human TLR2
or TLR4 were responsive to M. tuberculosis. TLR2 knock-out mice displayed more than 50% defective cytokine
production after stimulation with mycobacteria, whereas TLR4-defective mice also released 30% less cytokines
compared to controls. Similarly, HEK293T cells transfected with NOD2 responded to stimulation with M. tuberculosis.
The important role of NOD2 for the recognition of M. tuberculosis was demonstrated in mononuclear cells of
individuals homozygous for the 3020insC NOD2 mutation, who showed an 80% defective cytokine response after
stimulation with M. tuberculosis. Finally, the mycobacterial TLR2 ligand 19-kDa lipoprotein and the NOD2 ligand
muramyl dipeptide synergized for the induction of cytokines, and this synergism was lost in cells defective in either
TLR2 or NOD2. Together, these results demonstrate that NOD2 and TLR pathways are nonredundant recognition
mechanisms of M. tuberculosis that synergize for the induction of proinflammatory cytokines.
Citation: Ferwerda G, Girardin SE, Kullberg B, Le Bourhis L, De Jong DJ, et al. (2005) NOD2 and Toll-like receptors are nonredundant recognition systems of Mycobacterium
tuberculosis. PLoS Pathog 1(3): e34.
Introduction
Worldwide, 2 billion people are currently believed to be
infected with Mycobacterium tuberculosis, with an estimated
death toll of 2 million patients each year [1]. M. tuberculosis is
an intracellular pathogen capable of infecting and surviving
within the host’s mononuclear cells (MNCs), and a coordi-
nated response of the innate and adaptive immune systems is
required for an effective host defense. This involves seques-
tration of the microorganism in macrophages within organ-
ized granulomas, and elimination of the pathogen through a
combination of killing mechanisms and apoptosis of host
macrophages [2]. These responses are coordinated by T
helper 1-type proinﬂammatory cytokines, which are synthe-
sized by phagocytes upon recognition of pathogen-associated
molecular patterns of mycobacteria by pattern recognition
receptors (PRRs).
Toll-like receptors (TLRs) are believed to be an important
pattern recognition system of M. tuberculosis. A soluble, heat-
stable mycobacterial fraction was initially reported to signal
through TLR2, whereas heat-labile components associated
with the cell wall were reported to signal through TLR4 [3].
Later, several components of mycobacteria were identiﬁed as
being responsible for TLR2-dependent activation: the 19-kDa
lipoprotein [4], lipomannan [5], phosphatidyl-myo-inositol
mannoside [6], but not mannosyl-caped lipoarabinomannan
from virulent M. tuberculosis, which mainly has anti-inﬂam-
matory effects through its interaction with the mannose
receptor and dendritic cell-speciﬁc intercellular adhesion
molecule 3-grabbing nonintegrin, also termed DC-SIGN [7,8].
Despite an abundance of in vitro data regarding the
recognition of mycobacterial structures by TLR2 and TLR4,
knock-out mice deﬁcient for these receptors display remark-
ably little enhanced susceptibility to infection with M.
tuberculosis. TLR4
 /  mice showed variable responses to the
challenge with M. tuberculosis, with either normal resistance to
infection [9,10] or chronic pneumonia and increased mortal-
ity [11,12]. In one study, TLR2
 /  mice had a decreased
clearance of the bacteria and developed chronic pneumonia
when infected with a low dose of microorganisms [13],
whereas in other studies only minor effects have been found
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was further highlighted in mice deﬁcient for MyD88 (an
adaptor molecule shared by almost all the receptors of the
TLR family), which are highly susceptible to M. tuberculosis
infection [15].
Nucleotide-binding oligomerization domain 2 (NOD2), initially
described as a susceptibility gene for Crohn’s disease [16,17],
is an intracellular protein containing leucine-rich repeats
(LRRs) similar to those found in TLRs. NOD2 is the PRR
responsible for recognition of bacterial peptidoglycans from
both gram-positive and gram-negative bacteria, through its
interaction with muramyl dipeptide (MDP) [18]. In contrast,
NOD1 recognizes peptidoglycans of gram-negative bacteria
only [19]. The intracellular localization of both NOD2 and M.
tuberculosis, the cell wall of which contains peptidoglycans,
makes NOD2 a highly suitable candidate for the recognition
of mycobacteria. Our results support the hypothesis that
TLRs and NOD2 represent two nonredundant recognition
systems of M. tuberculosis, and that an efﬁcient activation of
innate immunity requires both classes of receptors.
Results
The Role of TLR2 and TLR4 in the Recognition of M.
tuberculosis
TLR2 and TLR4 have been suggested to recognize bacterial
structures of M. tuberculosis [20]. Indeed, a sonicate of M.
tuberculosis strongly activated a Chinese hamster ovary
ﬁbroblast (CHO) cell line cotransfected with human TLR2
and CD14, whereas cells transfected with CD14 alone or a
combination of CD14 and TLR4 displayed no signaling upon
activation with the sonicated mycobacterial preparation
(Figure 1A). However, when cells were stimulated with a
preparation of whole mycobacteria, both TLR2 and TLR4-
transfected cells were activated, although TLR2 activation
was stronger (Figure 1A).
In line with these data, macrophages isolated from TLR2
 / 
mice displayed a 50%–75% reduction in tumor necrosis
factor (TNF) production after stimulation with both M.
tuberculosis preparations (Figure 1B), whereas TLR4-deﬁcient
macrophages showed a 30%–40% reduction of TNF release
only when stimulated with the whole mycobacteria (Figure
1C). To conﬁrm the role of TLR4 in the stimulation of
cytokines by M. tuberculosis, we stimulated human MNCs with
the whole mycobacterial preparation in the absence or
presence of 10 lg/ml of a blocking anti-TLR4 antibody.
TLR4 blockade completely inhibited lipopolysaccharide
(LPS)-induced TNF secretion, and reduced M. tuberculosis-
induced TNF secretion from 0.9 6 0.2 to 0.5 6 0.2 ng/ml (p ,
0.05). These data conﬁrm the role played by TLR2 and TLR4
in the recognition of M. tuberculosis; however, the signiﬁcant
remaining production of cytokines induced by M. tuberculosis
Figure 1. TLR2 and TLR4 Are Partially Responsible for Induction of
Cytokine Production by M. tuberculosis
(A) CHO cells cotransfected with CD14 and TLR2 (CD14/TLR2, hatched
bars) induced potent expression of CD25 on the cell membrane as
measured by FACS analysis, after stimulation with both a sonicated M.
tuberculosis (MTB-son, 1 lg/ml) or whole mycobacteria (MTB-whole, 1 3
10
7/ml). In contrast, cells transfected with CD14 and TLR4 (CD14/TLR4,
black bars) were only moderately activated by whole M. tuberculosis, but
not by the sonicated material. LPS (1 lg/ml) and Pam3Cys (5 lg/ml)
served as control stimuli for TLR4 and TLR2, respectively. As controls,
cells transfected only with CD14 were used (white bars).
(B and C) Stimulation of TNF production by M. tuberculosis in peritoneal
macrophages of mice deficient for TLR2 (TLR2-KO) (B) or TLR4 (TLR4-def)
(C). Groups of five mice were stimulated with the indicated reagents, and
the experiment was repeated twice. Medium-stimulated cells resulted in
cytokine concentrations below detection limit.
Data are presented as mean 6 SD (n ¼ 5; *p , 0.05).
DOI: 10.1371/journal.ppat.0010034.g001
PLoS Pathogens | www.plospathogens.org November 2005 | Volume 1 | Issue 3 | e34 0280
Recognition of M. tuberculosis by NOD2
Synopsis
Tuberculosis is one of the most prevalent infections worldwide, with
2 billion people believed to be infected, and 2 million deaths each
year. In addition to representing a major health care problem in
developing countries, concern is also growing about the increased
incidence of tuberculosis in developed countries, especially in
immunocompromised patients such as those with AIDS, trans-
plantation, and immunosuppressive therapy. The present study
describes the pathways that enable leukocytes to recognize M.
tuberculosis, and demonstrates for the first time that NOD2, member
of a new class of intracellular receptors, is an independent
recognition mechanism for mycobacteria. NOD2 acts together with
the earlier-described Toll-like receptors for the activation of host
defenses during the encounter of leukocytes with M. tuberculosis.
Understanding the mechanisms through which the cells of the
immune system recognize M. tuberculosis can be an important step
in designing new therapeutic approaches, as well as improving the
limited success of current vaccination strategies.in TLR2
 /  or TLR4-defective mice points to the presence of
additional signaling pathway(s) for cytokine induction.
The Role of Intracellular Recognition Systems in the
Recognition of M. tuberculosis
The role of internalization in cytokine induction by M.
tuberculosis was assessed by blocking it with cytochalasin B, an
inhibitor of actin polymerization. Blocking internalization of
M. tuberculosis partially inhibited M. tuberculosis-induced
cytokine release in freshly isolated human MNCs (Figure 2).
In contrast, cytochalasin B increased the zymosan-induced
cytokine production in these MNCs, which likely results from
prolonged stimulation of receptors at the cell surface by
zymosan. The difference in the effect of cytochalasin B on M.
tuberculosis- or zymosan-induced cytokines strongly suggests
that internalization of M. tuberculosis is important for the
induction of cytokine production through intracellular
receptors.
The Role of NOD1 and NOD2 in the Recognition of M.
tuberculosis
Next, human embryonic kidney 293T cells (HEK293Ts)
were transfected with either NOD1 or NOD2 expression
vectors, and the ability of M. tuberculosis sonicates to activate
these pathogen recognition receptors was followed by
monitoring the level of NOD-dependent activation of a
nuclear factor jB (NF-jB)-driven luciferease reporter gene.
Strikingly, M. tuberculosis sonicates efﬁciently stimulated
NOD2, while NOD1-transfected cells responded only modestly
to the bacteria (Figure 3).
To investigate further the role of NOD1 and NOD2 in the
recognition of M. tuberculosis, we stimulated peritoneal
macrophages from NOD1
 /  or NOD2
 /  mice. We observed
that peritoneal macrophages from NOD2
 /  mice produced
signiﬁcantly less TNF than did control cells, supporting a role
of NOD2 in the recognition of M. tuberculosis (Figure 4). In
contrast, macrophages from NOD1
 /  mice responded nor-
mally to M. tuberculosis (Figure 4), although as a control, their
response to the NOD1 ligand FK156 was abrogated (unpub-
lished data). Together, these results strongly support the
notion that NOD2 represents an intracellular recognition
system for M. tuberculosis.
Stimulation of Cells from Patients with Defective NOD2
Recognition
In line with the hypothesis that NOD2 is involved in the
recognition of mycobacteria, MNCs isolated from patients
homozygous for the 3020insC mutation synthesized 65%–80%
less cytokines after stimulation with M. tuberculosis than did
Crohn’s disease patients heterozygous for the mutation or
patients and volunteers homozygous for the wild-type variant
(Figure 5A). This demonstrates that NOD2 is critical for the
recognition of M. tuberculosis cell wall. In control experiments,
cells from patients homozygous for the 3020insC mutation
were defective in their response to MDP, but not LPS (Figure
5B), as previously described [21].
TLR2 and NOD2 Synergize for the Induction of Cytokine
Release
In order to study the cross talk between TLR2 and NOD2 in
the recognition of M. tuberculosis, we investigated whether
mycobacterial TLR2 and NOD2 ligands synergize for the
induction of cytokine release. Indeed, the NOD2 ligand MDP,
the minimal component of peptidoglycan responsible for
NOD2 activation, had strong synergistic effect on TNF
production induced by the 19-kDa lipoprotein of M. tuber-
culosis, a speciﬁc mycobacterial TLR2 ligand (Figure 6A).
Similar synergistic effects between the 19-kDa lipoprotein
and MDP were observed when IL-6 (4.5-fold synergism), and
IL-1b (7.2-fold synergism) were measured. This synergism was
lost in individuals homozygous for the NOD2 3020insC
mutation (Figure 6B) or macrophages harvested from
TLR2
 /  mice (5.7-fold synergism between lipoprotein 19-
kDa and FK-156 in control macrophages, and 1.9-fold
synergism in TLR2
 /  cells). No such synergy was observed
between MDP and mannosyl-caped lipoarabinomannan, a
component of M. tuberculosis that does not interact with TLR2
(unpublished data).
Discussion
In the present study, we investigated the role of TLRs and
NODs, the two most important classes of PRRs in the
recognition by macrophages of M. tuberculosis. Although we
conﬁrmed the role of TLR2 and TLR4 for in mycobacterial
recognition, strong residual activity was detectable in cells
lacking TLR2, which suggests the existence of TLR-independ-
ent recognition mechanisms; this idea is supported by a study
demonstrating MyD88-independent pathways of macrophage
stimulation by M. tuberculosis [22]. Using cell lines transfected
with NOD1 and NOD2, as well as primary MNCs defective in
these receptors, we demonstrated that, in addition to TLRs,
NOD2 represents a nonredundant recognition system of M.
tuberculosis. We also demonstrated that mycobacterial TLR2
and NOD2 ligands synergize for the production of proin-
Figure 2. Blockade of Internalization of M. tuberculosis Impairs
Recognition and Cytokine Production
Blockade of M. tuberculosis internalization by cytochalasin B (20 lg/ml)
impairs TNF (A) and IL-10 (B) stimulation in human MNCs stimulated with
sonicated M. tuberculosis (1310
6 microorganisms/ml), but not zymosan
(1 lg/ml). Data are presented as mean 6 SD (n ¼ 5; *p , 0.05).
DOI: 10.1371/journal.ppat.0010034.g002
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Recognition of M. tuberculosis by NOD2ﬂammatory cytokines, and that this synergism is lost in cells
lacking either of these receptors.
Several studies have demonstrated the role of TLR2 and
TLR4 in the recognition of M. tuberculosis. The 19-kDa
lipoprotein [4], lipomannan [5], and phosphatidyl-myo-
inositol mannoside [6], all components of mycobacteria, have
been identiﬁed as being responsible for TLR2-dependent
activation, whereas heat-labile components associated with
the cell wall were found to signal via TLR4 [3]. A role for
TLRs in antimycobacterial defense was also suggested by the
enhanced susceptibility to M. tuberculosis infection in mice
deﬁcient for MyD88, an adapter molecule shared by almost all
TLR family members [15]. Similarly, TLR2
 /  mice had a
decreased clearance of the bacteria and developed chronic
pneumonia when infected with low doses of microorganisms
[9,13,14], whereas TLR4
 /  mice showed variable responses to
challenge with M. tuberculosis [9,10].
Our data conﬁrm the important role played by TLRs, and
especially TLR2, in the recognition of M. tuberculosis, but at
the same time demonstrate strong TLR-independent induc-
tion of cytokines by this microorganism. The contribution of
TLR4 was found to be less crucial in our study, and could be
observed only when cells were stimulated with intact micro-
organisms.
Because M. tuberculosis is an intracellular pathogen, we
hypothesized that intracellular recognition systems could
contribute to the sensing of mycobacteria and stimulation of
innate immunity. To test this hypothesis, we studied the effect
of blocking the internalization of M. tuberculosis with
cytochalasin B. Blocking internalization of M. tuberculosis
partially inhibited M. tuberculosis-induced cytokine release in
MNCs, whereas cytochalasin B potentiated the cytokine
induction by zymosan, likely due to prolonged stimulation
of receptors at the cell surface by zymosan. The differential
effects of cytochalasin B on M. tuberculosis- or zymosan-
induced cytokine secretion demonstrate that, in addition to
the interaction with cell-membrane bound TLRs, M. tuber-
culosis is recognized by and induces cytokine production
through intracellular receptors.
NOD2 and NOD1 are members of the expanding CATER-
PILLER family of proteins, which share an LRR domain
similar to that found in TLRs [23]. NOD2 has been linked
genetically to increased risk for Crohn’s disease [16,17], and is
a sensor of bacterial peptidoglycans [18]. When HEKs
transfected with either NOD1 or NOD2 were stimulated with
M. tuberculosis cell wall preparations, both of them—but most
markedly those transfected with NOD2—showed a dose-
dependent response. These data are consistent with the
conclusion that NOD2 is a general sensor of bacteria through
the detection of MDP, a peptidoglycan substructure present
in bacterial cell walls [18]. However, the fact that NOD1 was
found to be a poor sensor of M. tuberculosis not only in NOD1-
transfected HEK cells, but also through the lack of a defective
response in NOD1
 /  macrophages, is somewhat puzzling.
Indeed, NOD1 detects diaminopimelic acid (DAP)-type
peptidoglycans, and earlier reports had suggested that M.
tuberculosis peptidoglycan is of this category. Further inves-
tigation is therefore required to discover why NOD1 detects
M. tuberculosis poorly.
To test whether the data in transfected cell lines could be
reproduced in primary cells, we stimulated MNCs isolated
from Crohn’s disease patients homozygous for the 3020insC
null-mutant allele with M. tuberculosis. This mutation leads to
the deletion of the last 32 amino acids of the LRR region
responsible for the detection of peptidoglycan, and we have
recently shown that cells isolated from these patients are
completely unable to recognize MDP or gram-positive
peptidoglycan [21]. In line with the hypothesis that NOD2 is
involved in the recognition of mycobacteria, both peritoneal
macrophages from NOD2-deﬁcient mice and MNCs isolated
from patients homozygous for the 3020insC mutation of
NOD2 were found to synthesize signiﬁcantly less cytokines
after stimulation with M. tuberculosis. Interestingly, the very
strong defect in the response to M. tuberculosis of the cells of
patients with the NOD2 3020insC mutation suggests that
Figure 3. Stimulation of HEK Cells Transfected with NOD1 or NOD2
HEKs transfected with NOD2 were strongly activated by whole M.
tuberculosis, in contrast to cells transfected with NOD1, which were only
weakly activated by M. tuberculosis. MDP (100 nM) and TriDAP (100 nM)
served as control stimuli for NOD2 and NOD1, respectively. Data are
presented as fold increase over unstimulated cells (mean 6 SD).
DOI: 10.1371/journal.ppat.0010034.g003
Figure 4. Stimulation of Cells from Mice Deficient in NOD1 or NOD2
Stimulation of cytokine production by sonicated M. tuberculosis in
peritoneal macrophages of mice deficient for either NOD1 (A) or NOD2
(B). Groups of four mice were stimulated; medium-stimulated cells
resulted in cytokine concentrations below detection limit.
Data are presented as mean 6 SD (*p , 0.05).
DOI: 10.1371/journal.ppat.0010034.g004
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recognition. This is in line with the weak stimulation of
NOD1-transfected HEKs by M. tuberculosis and our recent
ﬁnding that NOD2 is needed for normal signaling by NOD1
ligands such as Mur-Tri-DAP [24]. The reverse is not true in
the case of NOD1: Macrophages harvested from NOD1
 / 
mice responded normally to M. tuberculosis, demonstrating
that the absence of NOD1 can be compensated by other
recognition systems, most likely NOD2.
The ﬁnding of strongly reduced cytokine production after
stimulation with M. tuberculosis in cells of patients with a
defective NOD2 and of NOD2 knock-out mice demonstrates
that NOD2 is a key sensor of M. tuberculosis in mammalian
cells. Interestingly, inhibition of both NOD2 and TLR2
systems blocked stimulation of cytokines by M. tuberculosis
by substantially more than 50%. This suggests that the
signaling pathways induced by these receptors interact and
potentiate each other, and, conversely, that defects in one
pathway lead to a loss of synergy. We have recently shown that
NOD2 signals strongly synergize with speciﬁc TLR pathways
such as TLR2, TLR4, and TLR3 [25]. We therefore inves-
tigated whether NOD2 activation leads to similar synergistic
cytokine stimulation by TLR2 ligands speciﬁcally derived
from M. tuberculosis. Indeed, MDP had strong synergistic effect
on the cytokine production induced by the 19-kDa lip-
oprotein of M. tuberculosis, and this synergy was lost both in
individuals homozygous for the NOD2 3020insC mutation and
in macrophages harvested from TLR2
 /  mice.
An issue yet to be resolved is represented by the
mechanism through which mycobacterial peptidoglycans
come in contact with NOD2. NOD2 is an intracytoplasmic
molecule, while M. tuberculosis remains located mainly in
phagosomes. Although shedding of cell wall components
from the microorganism is likely responsible for the release
of peptidoglycans that are ultimately recognized by NOD2,
the precise mechanism through which peptidoglycans trans-
locate from the phagosome into the cytoplasm remains to be
identiﬁed.
The data presented in this study demonstrate that NOD2
and TLRs are two nonredundant recognition mechanisms of
M. tuberculosis. Both are essential for effective activation of the
proinﬂammatory cytokine production by M. tuberculosis, and
they strengthen each other’s activity through synergistic
effects. This demonstrates that host cells sense the presence
of M. tuberculosis using multiple recognition systems in which
different classes of receptors, in this case NOD2 and TLRs,
interact with each other.
The involvement of NOD2 in the recognition of M.
tuberculosis has several implications. First, it is possible that
NOD2 is involved in recognition of other gram-positive
bacteria with cell walls rich in peptidoglycans. The recent
report of NOD2 serving as a receptor for Streptococcus
pneumoniae supports this idea [26]. Second, our data suggest
that NOD2 is involved in the recognition of other Mycobacteria
species. From this point of view, M. paratuberculosis is of
particular interest, due to its possible involvement in the
Figure 5. Human NOD2 Is a Receptor for M. tuberculosis
(A) MNCs isolated from four patients with Crohn’s disease homozygous
for the 3020insC NOD2 mutation (NOD2fs), five patients heterozygous for
NOD2 mutations (NOD2het), five patients with the wild-type NOD2 allele
(NOD2WT), and five healthy volunteers with wild-type NOD2 (control)
were stimulated with 10 lg/ml sonicated M. tuberculosis. TNF (white
bars) and IL-10 (black bars) were measured after 24 h of stimulation at 37
8C by specific RIA and ELISA, respectively.
(B) MNCs isolated from four patients with Crohn’s disease homozygous
for the 3020insC NOD2 mutation (NOD2fs, black bars), five patients with
the wild-type NOD2 allele (NOD2WT, gray bars), and five healthy
volunteers with wild-type NOD2 (control), were stimulated with 1 lg/ml
MDP or 10 ng/ml LPS. TNF were measured after 24 h of stimulation at 37
8C by specific RIA. Medium-stimulated cells resulted in cytokine
concentrations below detection limit.
Data are presented as mean 6 SD (*p , 0.05).
DOI: 10.1371/journal.ppat.0010034.g005
Figure 6. NOD2 and TLR2 Have Synergistic Effects on Cytokine
Production
(A) MNCs isolated from five healthy volunteers with wild-type NOD2 were
costimulated with 1 lg/ml MDP and increasing concentrations of 19-kDa
lipoprotein (indicated on the x-axis). TNF was measured after 24 h of
stimulation at 37 8C by specific RIA.
(B) The synergistic effects observed in the five control volunteers, as well
as in five Crohn’s disease patients heterozygous for NOD2 mutations
(NOD2-het), and in five patients with the wild-type NOD2 allele (NOD2-
WT), was lost in patients homozygous for the NOD2 3020insC mutation.
Medium-stimulated cells resulted in cytokine concentrations below
detection limit. Data are presented as mean 6 SD (*p , 0.05).
DOI: 10.1371/journal.ppat.0010034.g006
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against M. paratuberculosis in individuals bearing loss-of-
function NOD2 mutations may be responsible for the invasion
of the intestine and may promote chronic inﬂammation
ultimately leading to Crohn’s disease. This hypothesis is
supported by the recently described presence of M. para-
tuberculosis in the circulation of patients with Crohn’s disease
[28]. Regarding the role of NOD2 in tuberculosis, one must,
however, acknowledge that the present study provides
information only on the in vitro recognition of M. tuberculosis,
and studies investigating the role of NOD2 in infection
models are warranted.
In conclusion, NOD2 and TLRs appear to serve as
independent, nonredundant PRRs of M. tuberculosis. The
intracellular pathways induced by NOD2 and TLR2 during
recognition of mycobacterial components synergize, and the
stimulation of cytokine production by M. tuberculosis is greatly
impaired in individuals with NOD2 mutations.
Materials and Methods
Reagents and microorganisms. Synthetic Pam3Cys and 19-kDa
lipoprotein were purchased from EMC Microcollections (Tu ¨bingen,
Germany). MDP and LPS (E. coli serotype 055:B5) were purchased
from Calbiochem (San Diego, California, United States) and Sigma
(St. Louis, Missouri, United States), respectively. The synthetic MDP
was tested for contamination with lipoproteins or LPS in mice
deﬁcient in TLR2 or TLR4, respectively. No defect in cytokine
production was apparent in these mice after stimulation with MDP,
demonstrating the absence of contamination.
Cultures of M. tuberculosis H37Rv were grown to mid-log phase in
Middlebrook 7H9 liquid medium supplemented with oleic acid/
albumin/dextrose/catalase (Difco, Becton-Dickinson, Palo Alto, Cal-
ifornia, United States), washed three times in sterile saline, and
resuspended in RPMI 1640 medium at the various concentrations.
Separate culture suspensions were sonicated for 10 min on ice, in
order to obtain cell lysates.
Genotyping of NOD2 variants. Blood was collected from 74 patients
with Crohn’s disease and ten healthy volunteers. PCR ampliﬁcation of
NOD2 gene fragments containing the polymorphic site 3020insC was
performed in 50-ll reaction volumes containing 100–200 ng of
genomic DNA as previously described [21]. The 3020insC poly-
morphism was analyzed by Genescan analysis on an ABI-Prism 3100
Genetic Analyzer according to the protocol of the manufacturer
(Applied Biosystems, Nieuwerkerk a/d IJssel, The Netherlands).
Four patients with Crohn’s disease were found to be homozygous
for the 3020insC mutation, and they were further investigated in the
cytokine studies. As control groups, ﬁve patients with Crohn’s disease
who were heterozygous for the 3020insC NOD2 mutation, ﬁve patients
with Crohn’s disease bearing the wild-type allele, and ﬁve healthy
volunteers homozygous for the wild-type NOD2 allele were included.
None of the patients with Crohn’s disease used immunosuppressive
medication at the time of the study.
Isolation of MNCs and stimulation of cytokine production. After
informed consent, venous blood was drawn from the cubital vein of
patients and healthy volunteers into three 10-ml EDTA tubes
(Monoject, s-Hertogenbosch, The Netherlands). Isolation of MNCs
was performed as described elsewhere [29], with minor modiﬁcations.
The MNC fraction was obtained by density centrifugation of blood
diluted 1:1 in pyrogen-free saline over Ficoll-Paque (Pharmacia
Biotech AB, Uppsala, Sweden). Cells were washed twice in saline and
suspended in culture medium (RPMI 1640 DM) supplemented with 10
lg/ml gentamicin, 10 mM L-glutamine, and 10 mM pyruvate. The cells
were counted in a Coulter counter (Coulter Electronics, Mijdrecht,
The Netherlands), and the number was adjusted to 5 3 10
6 cells/ml.
MNCs (5 3 10
5) were added in a 100-ll volume to round-bottom
96-well plates (Greiner, Alphen a/d Rijn, The Netherlands) and
incubated with either 100 ll of culture medium (negative control), or
the various stimuli: M. tuberculosis bacteria (1 3 10
5 to 1 3 10
7
microorganisms/ml), M. tuberculosis sonicate (10 lg/ml), MDP (1 lg/ml),
LPS (10 ng/ml), 19-kDa lipoprotein (concentrations as described
below), or combinations of MDP and 19-kDa lipoprotein. The
inﬂuence of internalization of M. tuberculosis on cytokine production
was investigated by adding 20 lg/ml cytochalasin B during stimulation
with the microorganism. Positive control stimulation for the effects
of cytochalasin B was provided by stimulation of cells with zymosan (1
lg/ml; Sigma). All stimuli were checked for the contamination with
LPS in the Limulus amoebocyte lysate assay and found to be negative.
Cytochalasin B did not inﬂuence cell viability (unpublished data). To
evaluate the role of TLR4 in the induction of cytokines, cells were
preincubated with 10 lg/ml of a blocking monoclonal anti-TLR4
antibody (eBioscience, San Diego, California, United States).
Cytokine production by murine peritoneal macrophages. Resident
peritoneal macrophages from either ScCr (TLR4-defective) or C57Bl/
10J (TLR4 control) mice, TLR2
 /  or control TLR2
þ/þ mice (kindly
provided by S. Akira, Osaka, Japan) [30], NOD1
 /  and NOD1
þ/þ
littermates (kindly provided by E. Abraham, Denver, Colorado,
United States), or NOD2
þ/þ and NOD2
 /  (from M. Giovannini,
CEPH, Paris), backcrossed to the seventh generation into the C57BL6/
J background, were harvested by injection of 4 ml of sterile PBS
containing 0.38% sodium citrate [31]. After centrifugation and
washing, the cells were resuspended in RPMI 1640 containing 1 mM
pyruvate, 2 mM L-glutamine, 100 lg/ml gentamicin, and 2% fresh
mouse plasma. Cells were cultured in 96-well microtiter plates
(Greiner) at 1 3 10
5 cells/well, in a volume of 100 ll. The cells were
stimulated with puriﬁed LPS (1 lg/ml), Pam3Cys (1 lg/ml), FK-156
ligand of murine NOD1 (1 lg/ml) as a control stimulation, or a
sonicate of M. tuberculosis (1 lg/ml). After 24 h incubation at 37 8C, the
supernatants were collected and stored at 70 8C until cytokine assays
were performed.
Cytokine measurements. Human and murine TNFa concentrations
were determined by speciﬁc RIAs as described [32,33]. IL-10 and IL-6
were measured by a commercial ELISA kits (Pelikine Compact, CLB,
Amsterdam, The Netherlands), according to the instructions of the
manufacturer.
Signaling through human TLR2 and TLR4 in transfected cell lines.
CHOs stably transfected with human CD14 (3E10-CD14), a combina-
tion of CD14 and TLR2 (3E10-TLR2), or TLR4 (3E10-TLR4), were a
kind gift from R. Ingalls [34]. All cell lines express inducible
membrane CD25 under control of a region from the human E-
selectin (ELAM-1) promoter containing NF-jB binding sites. Cells
were maintained at 37 8C and 5% CO2 in HAM’s F12 medium (Gibco,
Invitrogen, Breda, The Netherlands) supplemented with 10% FCS,
0.01% L-glutamine, 50 lg/ml gentamicin, and either 400 U/ml
hygromycin and 0.5 mg/ml of G418 (for 3E10-TLR2) or 0.05 mg/ml
of puromycin (for 3E10-TLR4) as additional selection antibiotics.
TLR2 and TLR4 expression was conﬁrmed by ﬂow cytometry (Coulter
Epics XL-MCL, Beckman Coulter, Mijdrecht, the Netherlands) using
PE-labeled anti-TLR2 (clone TL2.1) or anti-TLR4 (clone HTA125)
(Immunosource, Halle-Zoersel, Belgium).
For stimulation experiments, 500 ll of cells in culture medium at a
density of 1 3 10
5/ml were plated in 24-well culture plates. After an
overnight incubation, cells were incubated with control medium, M.
tuberculosis sonicate (10 lg/ml), Pam3Cys (10 lg/ml), or LPS (1 lg/ml)
for 20 h, and thereafter cells were harvested using trypsin/EDTA
(Cambrex, East Rutherford, New York, United States) and prepared
for ﬂow cytometry (Coulter FACS-scan). CD25 expression of the
CHOs was measured using FITC-labeled anti-CD25 (DAKO, Glostrup,
Denmark), and expressed as folds-over-mean increase.
Stimulation of NOD-transfected cell lines and NF-jB translocation.
Studies examining the activation of NF-jBb yM. tuberculosis in cells
overexpressing NOD1 or NOD2 were carried out as previously
described [19]. Brieﬂy, 1 3 10
6/ml HEK293T cells were transfected
overnight with 1 ng of either NOD1 or NOD2 plus 75 ng luciferase
reporter plasmid. At the same time, heat-killed whole M. tuberculosis
preparations (ratio of microorganisms and effector cells 1:10, 1:1, and
10:1) were added to cell culture medium, and the NF-jB–dependent
luciferase activation was then measured following 24 h of incubation.
NF-jB–dependent luciferase assays were performed in duplicate, and
data represent three independent experiments [19].
Statistical analysis. The human experiments were performed in
triplicate with blood obtained from patients and volunteers. The
mouse experiments were performed twice in 10 mice per group, and
the data are presented as cumulative results of all experiments
performed. The differences between groups were analyzed by
unpaired Student t-test, and where appropriate by paired t-test.
The level of signiﬁcance between groups was set at p , 0.05. The data
are given as means 6 standard deviation (SD).
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